Liver problems with Abbott Laboratories Inc.’s discontinued attention deficit drug Cylert and other generic versions are too dangerous for the U.S. market, the Food and Drug Administration said on Monday.

“The agency has concluded that the overall risk of liver toxicity from Cylert and generic pemoline products outweighs the benefits of this drug,” the FDA said in a warning posted on its Web site.

In March, Abbott said it would no longer make the drug due to declining sales, but consumer advocates had argued it was too dangerous to be sold.

 


Comments


View Comments / Leave a Comment

This post currently has 2 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 24 Oct 2005
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2005). Discontinued ADD drug too risky: FDA. Psych Central. Retrieved on November 22, 2014, from http://psychcentral.com/blog/archives/2005/10/24/discontinued-add-drug-too-risky-fda/

 

Recent Comments
  • regular mom: It is down right hurtful to hear people say disorders like these are “made up” and used.to...
  • april banlawi: dipression is a sirous desease , i have been diagnose a general anxiety ,my phsyciatrist gave me a...
  • Purcell1984: I’m just 30 and I am already worried sick about ageing. I was bullied in my teen years and not...
  • Jonathan: I agree about avoiding sugar (nearly) entirely. But I would argue against the reasoning behind the...
  • Phoenix: …Suppose you are Addicted to your CHILD I am the Mother of 2 Daughters who claim I have ruined their...
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code



Users Online: 6993
Join Us Now!